Microbion Biosciences is a Bozeman, Montana, USA, biotechnology that is developing a new class of antibiotics....
Fantastic news! We've Found the answer you've been seeking!
Question:
Transcribed Image Text:
Microbion Biosciences is a Bozeman, Montana, USA, biotechnology that is developing a new class of antibiotics. The primary market that Microbion intends to develop is the diabetic foot ulcer (DFU) market for North America. The International Diabetes Federation Atlas indicates that in 2015 there were 44 million people in North America with diabetes, and this population is expected to grow to 61 million in 2040. Microbion's studies indicate that about 10% of people with diabetes in North America develop chronic foot ulcers and would benefit from their product. Microbion believes that it will successfully have a DFU product on the market by Jan 1, 2019. The total market unit sales in 2019 is forecast to be 440,000 units, and Microbion believes that it can get 20% of that total market. Microbion forecasts that total market size will increase by 1.5% each year through at least 2040. Unfortunately, Microbion's patent protection expires on December 31, 2026, so Microbion expects to have only 7 years of patent protection for its product. Upon the expiration of the patent, generics are expected to enter the market and decrease the market price of the product such that cash flows after the patent expiration will have zero net present value. The expected product price for the Microbion DFU product is $1200, and that price is expected to hold through Microbion's patent protection period which ends at the end of 2026 (although inflation would be expected to push prices up, the market power of federal government is expected to keep prices constant). Prices will adjust downward in 2027 when generics enter the market. The total costs of goods sold of producing the product are 20% of sales, and the sales, general and administrative expenses are expected to be 30% of sales. In order to continue with this project, Microbion will need to invest $21,000,000 on January 1, 2017 for the Phases 3 study which is expected to be completed in September 2017. This investment will be depreciated on a straight line basis for 7 years (through 2025), but the first year of depreciation will not occur until 2019, which is the first year of positive revenue. In addition, Microbion will need to increase the Net Working Capital of the company in 2019 by $2,000,000. These funds WILL NOT be returned at the end of the project. The probability that Microbion will successfully complete the Phase 3 study and have its DFU product accepted for the market is 75%. You have done sufficient due diligence on the numbers that Microbion has provided and have confirmed from your own sources that they are appropriate. You have determined that the appropriate cost of capital for this project is 18%. The corporate tax rate for Microbion is 35%. You also know that a multiplier of 1.2 times last year's sales is a multiplier used for valuation in the antibiotic industry. Based on the information that you have already collected and any assumptions that you need to make, determine a valuation for Microbion as if it is January 1, 2017. Clearly explain and justify how you arrived at this valuation. Discuss the different valuation approaches that are available to you, and explain why you used the approach(es) that you used. Microbion Biosciences is a Bozeman, Montana, USA, biotechnology that is developing a new class of antibiotics. The primary market that Microbion intends to develop is the diabetic foot ulcer (DFU) market for North America. The International Diabetes Federation Atlas indicates that in 2015 there were 44 million people in North America with diabetes, and this population is expected to grow to 61 million in 2040. Microbion's studies indicate that about 10% of people with diabetes in North America develop chronic foot ulcers and would benefit from their product. Microbion believes that it will successfully have a DFU product on the market by Jan 1, 2019. The total market unit sales in 2019 is forecast to be 440,000 units, and Microbion believes that it can get 20% of that total market. Microbion forecasts that total market size will increase by 1.5% each year through at least 2040. Unfortunately, Microbion's patent protection expires on December 31, 2026, so Microbion expects to have only 7 years of patent protection for its product. Upon the expiration of the patent, generics are expected to enter the market and decrease the market price of the product such that cash flows after the patent expiration will have zero net present value. The expected product price for the Microbion DFU product is $1200, and that price is expected to hold through Microbion's patent protection period which ends at the end of 2026 (although inflation would be expected to push prices up, the market power of federal government is expected to keep prices constant). Prices will adjust downward in 2027 when generics enter the market. The total costs of goods sold of producing the product are 20% of sales, and the sales, general and administrative expenses are expected to be 30% of sales. In order to continue with this project, Microbion will need to invest $21,000,000 on January 1, 2017 for the Phases 3 study which is expected to be completed in September 2017. This investment will be depreciated on a straight line basis for 7 years (through 2025), but the first year of depreciation will not occur until 2019, which is the first year of positive revenue. In addition, Microbion will need to increase the Net Working Capital of the company in 2019 by $2,000,000. These funds WILL NOT be returned at the end of the project. The probability that Microbion will successfully complete the Phase 3 study and have its DFU product accepted for the market is 75%. You have done sufficient due diligence on the numbers that Microbion has provided and have confirmed from your own sources that they are appropriate. You have determined that the appropriate cost of capital for this project is 18%. The corporate tax rate for Microbion is 35%. You also know that a multiplier of 1.2 times last year's sales is a multiplier used for valuation in the antibiotic industry. Based on the information that you have already collected and any assumptions that you need to make, determine a valuation for Microbion as if it is January 1, 2017. Clearly explain and justify how you arrived at this valuation. Discuss the different valuation approaches that are available to you, and explain why you used the approach(es) that you used.
Expert Answer:
Answer rating: 100% (QA)
To determine the valuation for Microbion as of January 1 2017 we can use a combination of valuation approaches including the discounted cash flow DCF ... View the full answer
Related Book For
Posted Date:
Students also viewed these accounting questions
-
Managing Scope Changes Case Study Scope changes on a project can occur regardless of how well the project is planned or executed. Scope changes can be the result of something that was omitted during...
-
Read the case study "Southwest Airlines," found in Part 2 of your textbook. Review the "Guide to Case Analysis" found on pp. CA1 - CA11 of your textbook. (This guide follows the last case in the...
-
Planning is one of the most important management functions in any business. A front office managers first step in planning should involve determine the departments goals. Planning also includes...
-
On 1 June 1998, Alice bought a house in Derby for 45,000. - She occupied the house as her PPR until 1 May 2000 when she left to work in Exeter, living in rented accommodation. - She returned to the...
-
Rancho Santa Fe Manufacturing, Inc., produces and sells a product with a price of $100 per unit. The following cost data have been prepared for its estimated upper and lower limits of activity:...
-
Wagner Co. is a cash-basis, calendar-year taxpayer. On August 1, 2019, it paid an insurance premium of $4,800 for coverage from August 1, 2019 to July 31, 2020. What is the largest deduction Wagner...
-
Data set: Ratings from 1 (lowest) to 10 (highest) provided by 36 people after taste testing a new flavor of ice cream. Construct a frequency distribution and a relative frequency histogram for the...
-
On January 1, 2013, Eagle borrows $ 100,000 cash by signing a four-year, 7% installment note. The note requires four equal total payments of accrued interest and principal on December 31 of each year...
-
Collegiate Publishing Inc. began printing operations on March 1. Jobs 301 and 302 were completed during the month, and all costs applicable to them were recorded on the related cost sheets. Jobs 303...
-
The CitruSun Corporation ships frozen orange juice concentrate from processing plants in Eustis and Clermont to distributors in Miami, Orlando, and Tallahassee. Each plant can produce 20 tons of...
-
watch the video and answer the questions. 5. In what ways did he improve his delivery? 6. What were his sources and how did they differ from his first attempt? 7. How did his overall performance...
-
How can we integrate data visualization and supplementary visual aids to augment the clarity and impact of our written reports and proposals ?
-
Solve the predator prey model developed in (a) above and use the solution to show that in the absence of the predators, the prey grows exponentially and in the absence of the prey the predator...
-
How do Reports and Proposals leverage empirical evidence to substantiate assertions and foster persuasive discourse ?
-
A linear analytical model of the automobile engine for the idle speed control system is shown in Fig. 2.245.The input of the system is the throule position that controls the rate of airflow into the...
-
In figure on the right, a beam of monochromatic light hits passes through three mediums, crossing two interfaces as shown below. The indices of refraction or material 1 and 3 are n = 1.33 and n3= 1....
-
Suppose the direct quote for sterling in New York is 1.1108-12. a) How much would 500,000 pounds cost in New York? b) What is the direct quote for dollars in London? How does bid/ask work in this...
-
APC16550D UART has a clock running at18.432 MHz and its baud rate is set to 2000.Determine the HEX contents of its DLM and DLL registers. Please can you explain step by step and in detail how you get...
-
On March 1, Midway Distribution Company is considering leasing a building and buying the necessary equipment to operate a public warehouse. Alternatively, the company could use the funds to invest in...
-
Using the data in Exercise 6-10, assume that during the second year of operations Master Plumbing Supply Co. had net sales of $4,200,000, wrote off $60,000 of accounts as uncollectible using the...
-
Financial information related to Joshua Tree Interiors for August and September 2010 is as follows: a. Prepare balance sheets for Joshua Tree Interiors as of August 31 and as of September 30, 2010.b....
-
Which of Lees junior analysts three statements is correct? A. Statement 1 B. Statement 2 C. Statement 3 Elaine Lee is an analyst at an investment bank covering the energy sector. She and her junior...
-
Titian faces long-term risk from ____ due to potential regulatory changes in the developing economies. Theresa Blass manages the Toptier Balanced Fund (the Fund) and recently hired John Yorkton, a...
-
Which of the statements made by Yorkton on ESG factors in investment analysis is correct? A. Statement 1 B. Statement 2 C. Statement 3 Theresa Blass manages the Toptier Balanced Fund (the Fund) and...
Study smarter with the SolutionInn App